BioDiscovery New Zealand Limited Company Profile

07:37 EDT 25th September 2017 | BioPortfolio

BDNZ is New Zealand’s leading centre of expertise on Bacillus thuringiensis (Bt) and high throughput screening (HTS) of invertebrate pests. Key activities include isolation and evaluation of Bt genes for use in transgenic plants, HTS of compounds produced by microbes isolated from diverse habitats for insecticidal, nematicidal and anti-microbial activities.


24, Balfour Road, Parnell
New Zealand


Phone: 6493097666
Fax: 6493097666

News Articles [247 Associated News Articles listed on BioPortfolio]

Burst fuel pipe to disrupt New Zealand flights through week

WELLINGTON, New Zealand (AP) — A rupture in the main pipeline carrying jet fuel to New Zealand's largest airport has disrupted the travel plans of thousands of people and is expected to cause fu...

Hop on! Wild rabbits surf on sheep to flee New Zealand flood

WELLINGTON, New Zealand (AP) — It was a woolly ride, but three wild rabbits managed to escape rising floodwaters in New Zealand by clambering aboard sheep and surfing to safety on their backs.

Nine Things New Zealand Must Do To Tackle The Child Obesity Crisis

Dr Stefanie Vandevijvere, Professor Boyd Swinburn A panel of 71 independent and government experts have undertaken an evaluation of New Zealand Government food environment policies, compared to intern...

Zealand Initiates First Phase 3 Trial with Dasiglucagon for the Treatment of Severe Hypoglycemia in Diabetes

Copenhagen, July 3, 2017 - Zealand Pharma A/S ("Zealand") announces the initiation of a multinational Phase 3 clinical trial of dasiglucagon in four countries (Austria, Germany, Canada and the U.S.). ...

Zealand Pharma: CORRECTION: Zealand reports results for the first three months of 2017 (unaudited)

This is a correction of the announcement from 15:04 17.05.2017 CEST. Reason for the correction: Attachment of full report missing in previous release Company announcement - No. 15 / 2017 Zealand r...

Bendamustine funding approved in New Zealand

New Zealand’s Pharmaceutical Management Agency PHARMAC has announced the approval of an agreement with…

Zealand, Orbit Discovery enter into research collaboration

Zealand Pharma and Orbit Discovery have entered into a multi-target research collaboration to identify novel peptide therapeutics using Orbit’s proprietary peptide display technology. Zealand ha...

Decision to award sole supply of metoprolol succinate in New Zealand

New Zealand’s Pharmaceutical Management Agency PHARMAC today announced the approval of an agreement…

PubMed Articles [395 Associated PubMed Articles listed on BioPortfolio]

A wealth of tobacco control research in New Zealand: time for the New Zealand Government to do its bit.

High incidence of medulloblastoma in Māori and Pacific populations in New Zealand.

In New Zealand from 1995-2010, the incidence of medulloblastoma at ages 1-19 years was significantly higher in Māori (relative risk 2.0) and in Pacific peoples (RR 2.1) than in New Zealand Europeans.

30-day mortality after percutaneous coronary intervention in New Zealand public hospitals (ANZACS-QI 18).

The aim of this report is to provide hospitals in New Zealand with data about their own outcomes for percutaneous coronary intervention (PCI) procedures and allow comparisons with other New Zealand un...

Ethnic disparities in the use of seclusion for adult psychiatric inpatients in New Zealand.

This study aims to investigate disparities in seclusion between Māori and non-Māori non-Pacific (nMnP) adults in mental health inpatient units in New Zealand.

Body mass index (BMI): association with clinicopathological factors and outcome of women with newly diagnosed breast cancer in New Zealand.

To identify associations of obesity with breast cancer and its outcome in a New Zealand population, including those treated with adjuvant chemotherapy.

Clinical Trials [34 Associated Clinical Trials listed on BioPortfolio]

Meningococcal B Vaccination in University Students

This study is the third in a series using the MenB vaccine from the National Institute of Public Health in Norway (NIPH). The vaccine was first made in response to a high incidence of dise...

Nab-pacliatxel Plus Gemcitabine in Korean Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Nab-paclitaxel (interchangeable with ABRAXANE and ABI-007) is a unique protein formulation of a noncrystalline, amorphous form of paclitaxel in an insoluble particle state. Nab-paclitaxel ...

Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong Kong

The purpose of this study is to assess the tolerability and safety of KRX-101 in treating persistent microalbuminuria in type 2 diabetic patients who are also being treated with stable, ma...

Do we Achieve the Goal of "No Worse Than Mild Pain" in Daily Clinical Practice?

With this study the investigators want to perform a prospective cross-sectional audit at Zealand University Hospital, Koege, Denmark. The aim is to investigate the actual pain treatment an...

Cytisine Pharmacokinetics and Dose Response (C-DRAKS 3 and C-DRAKS 4)

A number of pharmacotherapies are available for smoking cessation in New Zealand including nicotine replacement therapy, bupropion, an antidepressant medication and varenicline. Of these, ...

Companies [196 Associated Companies listed on BioPortfolio]

BioDiscovery New Zealand Limited

BDNZ is New Zealand’s leading centre of expertise on Bacillus thuringiensis (Bt) and high throughput screening (HTS) of invertebrate pests. Key activities include isolation and evaluation of B...

New Zealand Trade and Enterprise

New Zealand Trade and Enterprise is the New Zealand Government's national economic development agency. Through our network of offices worldwide, we aim to improve the international competitiveness and...

New Zealand Pharmaceuticals Ltd.

New Zealand Pharmaceuticals (NZP) is leading the way for the biotechnology industry development in New Zealand. It manufactures and exports pharmaceutical intermediates and diagnostics products for th...

Air New Zealand

Air New Zealand offers more direct flights to the South Pacific than any other airline, including non-stop flights from San Francisco, Los Angeles, Honolulu and Vancouver to New Z...

Australia-New Zealand Biotech Alliance

A Memorandum of Understanding between the Governments of New South Wales, Queensland, South Australia, Tasmania, Victoria, Western Australia, the Australian Capital Territory, the Northern Territory a...

More Information about "BioDiscovery New Zealand Limited" on BioPortfolio

We have published hundreds of BioDiscovery New Zealand Limited news stories on BioPortfolio along with dozens of BioDiscovery New Zealand Limited Clinical Trials and PubMed Articles about BioDiscovery New Zealand Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioDiscovery New Zealand Limited Companies in our database. You can also find out about relevant BioDiscovery New Zealand Limited Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record